The Centers for Medicare & Medicaid Services has just announced a change in the scheme of its coverage of bariatric surgery as a treatment for type II diabetes in morbidly obese persons. Nothing more than the most anecdotal evidence exists in the medical literature about the feasibilty of such a procedure in retarding the effects of diabetes in those who remain obese — which makes this decision by CMS somewhat circumspect.

Although the government agency is restricting coverage to those with certain criteria (BMI cutoffs) who have the procedure done in CMS-certified facilities, the effect of this provision on the quality of treatment for both highly prevalent conditions is anyone’s guess — without certain randomized clinical trials to absolutely document the procedure’s safety and efficacy (not to mention cost neutrality) with respect to overall healthcare delivery and prevention in this patient population. | LINK

Related Posts Within Doctor Pundit:

1. Future Diabetes Care Costs Present Major Problem, Even with Reform Diabetes may be known for other things than just a...
2. Obama Announces Regulations for Early Retirement Coverage Program The federal government is feeling magnanimous toward employer-sponsored healthcare coverage....
3. Mass. Governor Announces Plan to Help Small Business in State’s Turbulent Universal Coverage Environment One thing that Massachusetts has learned from its experience as...